Stay updated on Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The study record no longer lists the “2017 (U.S. NIH Grant/Contract)” identifier, and the site revision advances from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-19T15:22:56.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The study record describes a completed Phase 3 comparison of tislelizumab with chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma. It also provides trial eligibility, participating locations, study outcomes, publications, and protocol documents.
    Difference
    100%
    Check dated 2026-11-12T15:24:52.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-29T15:40:47.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-22T15:53:57.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2, while the study page remains an access-denied error.
    Difference
    0.2%
    Check dated 2026-10-15T16:19:51.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-08T16:12:56.000Z thumbnail image

Stay in the know with updates to Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.